Business Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps Last updated: August 13, 2026 5:31 am By admin Share 0 Min Read SHARE Novo Nordisk’s CEO conceded Eli Lilly is gaining market share even as oral Wegovy hits record prescriptions and the stock keeps falling. The post Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps appeared first on BeInCrypto… Share This Article Email Copy Link Print Previous Article Gold breaks six-month resistance as China, ETFs boost demand Next Article Anthropic in talks to acquire Decart for $6B to boost AI efficiency Leave a Comment Leave a ReplyCancel reply FacebookLikeXFollowInstagramFollowLinkedInFollowMediumFollowRSS FeedFollow Most Read Can ETH Price Flip $2800 Early or Repeat Its 2025 Rally Pattern? The Human Impact Of Having Too Few Nurses Dolly Parton’s estate accuses nephew of threatening to destroy her legacy The UK ambassador who called Trump ‘inept’ was reportedly disinvited from a Treasury Department dinner. The White House will have plenty more opportunities to shun him. Qivalis drives transformation in global trade finance with stablecoins Prime Video is on Chromecast and Android TV, plus YouTube on Fire TV Founders Who Sound Perfect Are Making a Leadership Mistake Their Teams Notice Immediately Project Trump to unveil $54B South Korean investment in Alaska LNG project Boeing just announced a major leadership shuffle for its troubled 737 Max team, and the head of the program is out